Literature DB >> 26093920

Distinctive Treg associated CCR4-CCL22 expression profile with altered frequency of Th17/Treg cell in the immunopathogenesis of Pemphigus Vulgaris.

R Asothai1, Vivek Anand1, Dayasagar Das1, Parul Singh Antil1, Sujay Khandpur2, V K Sharma2, Alpana Sharma3.   

Abstract

Pemphigus Vulgaris (PV), a relatively common autoimmune blistering disease in India, primarily mediated by anti-Desmoglein 3 (anti-Dsg3) autoantibodies. T-helper 17 (Th17) and T-regulatory (Treg) cells play significant role in regulating immune homeostasis in autoimmune disorders. To understand immunopathogenesis of PV, it is crucial to unfold the phenotypic expression and functional characteristics of these cells along with their specific homing chemokine receptor-ligand. This proposed study aims to unravel the functional expression of Th17 and Treg cells along with their specific homing chemokine receptor-ligand, transcription factors and cytokine levels to better understand the immunopathogenesis of PV. The Flow cytometry results showed decreased frequency of Treg cells and high number of Th17 cells (p<0.001) indicating immune dysregulation in PV. A significant increase (p<0.001) in the serum levels of Th17 associated molecules (IL-17A, CCL-20) and relative expression of RORγt, CCR6 and CCL20 was found in patients. For Treg cells, transcription factor FOXp3 was significantly lowered along with defective CCR4-CCL22 (p<0.05) that might be playing an ambiguous role in Treg generated immune regulation, leading to homing defect at lesional sites. This maiden study revealed the role of defective receptor-ligand interface that might have failed to suppress inflammatory milieu produced by Th17 cells thus promoting inflammation and contributing to immunopathogenesis of PV. This chemokine receptor-ligand can further be explored as potential target for development of novel therapies in PV.
Copyright © 2015 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  CCR4-CCL22); Chemokine receptor-ligand (CCR6-CCL20; Foxp3; Pemphigus Vulgaris (PV); Rorγt; Th17/treg cells

Mesh:

Substances:

Year:  2015        PMID: 26093920     DOI: 10.1016/j.imbio.2015.06.008

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  12 in total

Review 1.  Pemphigus: a Comprehensive Review on Pathogenesis, Clinical Presentation and Novel Therapeutic Approaches.

Authors:  Robert Pollmann; Thomas Schmidt; Rüdiger Eming; Michael Hertl
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 8.667

Review 2.  Targeted Therapies for Autoimmune Bullous Diseases: Current Status.

Authors:  Kyle T Amber; Roberto Maglie; Farzan Solimani; Rüdiger Eming; Michael Hertl
Journal:  Drugs       Date:  2018-10       Impact factor: 9.546

Review 3.  T-cell positioning by chemokines in autoimmune skin diseases.

Authors:  Jillian M Richmond; James P Strassner; Kingsley I Essien; John E Harris
Journal:  Immunol Rev       Date:  2019-05       Impact factor: 12.988

4.  T helper type 1 polarizing γδ T cells and Scavenger receptors contribute to the pathogenesis of Pemphigus vulgaris.

Authors:  Dayasagar Das; Vivek Anand; Sujay Khandpur; Vinod K Sharma; Alpana Sharma
Journal:  Immunology       Date:  2017-10-12       Impact factor: 7.397

Review 5.  The emerging role of T cells in pemphigus vulgaris: a systematic review.

Authors:  Farnaz Araghi; Sahar Dadkhahfar; Reza M Robati; Mohammadreza Tabary; Mohammad Shahidi-Dadras
Journal:  Clin Exp Med       Date:  2022-08-04       Impact factor: 5.057

6.  Increased Frequency of T Follicular Helper Cells and Elevated Interleukin-27 Plasma Levels in Patients with Pemphigus.

Authors:  Tina Hennerici; Robert Pollmann; Thomas Schmidt; Maria Seipelt; Björn Tackenberg; Christian Möbs; Kamran Ghoreschi; Michael Hertl; Rüdiger Eming
Journal:  PLoS One       Date:  2016-02-12       Impact factor: 3.240

Review 7.  Role of Regulatory Immune Cells and Molecules in Autoimmune Bullous Dermatoses.

Authors:  Tianyu Cao; Shuai Shao; Hui Fang; Bing Li; Gang Wang
Journal:  Front Immunol       Date:  2019-08-02       Impact factor: 7.561

8.  Modifications of the Transcriptomic Profile of Autoreactive B Cells From Pemphigus Patients After Treatment With Rituximab or a Standard Corticosteroid Regimen.

Authors:  Vivien Hébert; Marie Petit; Maud Maho-Vaillant; Marie-Laure Golinski; Gaëtan Riou; Céline Derambure; Olivier Boyer; Pascal Joly; Sébastien Calbo
Journal:  Front Immunol       Date:  2019-08-07       Impact factor: 7.561

Review 9.  Common Denominators in the Immunobiology of IgG4 Autoimmune Diseases: What Do Glomerulonephritis, Pemphigus Vulgaris, Myasthenia Gravis, Thrombotic Thrombocytopenic Purpura and Autoimmune Encephalitis Have in Common?

Authors:  Inga Koneczny; Vuslat Yilmaz; Konstantinos Lazaridis; John Tzartos; Tobias L Lenz; Socrates Tzartos; Erdem Tüzün; Frank Leypoldt
Journal:  Front Immunol       Date:  2021-01-29       Impact factor: 7.561

Review 10.  Treg: A Promising Immunotherapeutic Target in Oral Diseases.

Authors:  Yujing Zhang; Jihua Guo; Rong Jia
Journal:  Front Immunol       Date:  2021-06-10       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.